
Organization · Private Equity
Gen Trust Capital
Gen Trust Capital is a private equity firm based in Shanghai, China, focusing on growth-stage investments in the information technology and healthcare sectors. It manages nearly 3 billion RMB across multiple funds.
Overview
What Gen Trust Capital does
What Gen Trust Capital is
Gen Trust Capital is a private equity firm based in Shanghai, China, focusing on growth-stage investments in the information technology and healthcare sectors. It manages nearly 3 billion RMB across multiple funds.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Gen Trust Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Gen Trust Capital as a funder
Investment thesis
Gen Trust Capital focuses on growth-stage investments in the information technology and healthcare sectors, particularly in semiconductors and biomedicine. It targets Series A to pre-IPO rounds.
Focus narrative
Gen Trust Capital focuses on investments in the information technology sector, primarily in semiconductors, and the healthcare sector, particularly in biomedicine. The organization targets growth-stage investments, covering Series A to pre-IPO rounds.
Focus and fit
- Stages
- Series A · Pre-IPO · Growth Equity
- Regions
- Asia
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- 康方生物, 皓元医药, 澳华内镜, 伟测科技, 纳芯微, and 力芯微, plus 2 more
Portfolio context
Notable portfolio companies include 康方生物 (Kangfang Biotechnology), 皓元医药 (Haoyuan Pharmaceutical), 澳华内镜 (Aohua Endoscopy), 伟测科技 (Weic Technology), 纳芯微 (Naxin Micro), 力芯微 (Lixin Micro), 三维天地 (Sanwei Tiandi), and 先锋精科 (Xianfeng Jingke). One investment has been acquired through a stock swap by a publicly listed company, and five companies are planning to apply for IPOs within the year.
Connected ecosystem
Continue from Gen Trust Capital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Gen Trust Capital
Upseed classifies Gen Trust Capital under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.